Andy G. Hinson

Vice President, Clinical and Regulatory Affairs
Mr. Hinson joined Cardio Polymers in November 2004. Mr. Hinson has over 20 years bio-pharmaceutical industry experience in regulatory strategy and clinical development in a variety of cardiovascular areas including arrhythmia, heart failure, hypertension and myocardial injury. Hinson also has extensive experience managing clinical trials for new biologic-based therapies. Prior to Cardio Polymers, Mr. Hinson was senior director of clinical development at AnGes Inc, a biotechnology firm developing novel gene-based approaches for the treatment of cardiovascular disease. Earlier, Mr. Hinson was senior manager of medical and scientific affairs at Procter & Gamble Pharmaceutical. Mr. Hinson holds a B.S. in Biochemistry from the University of Cincinnati.